This peer-to-peer exchange highlights results of a study that tested whether analyzing circulating tumor DNA (ctDNA) during treatment with chemoradiotherapy could predict outcomes in patients with localized lung cancer.
Maximilian Diehn, MD, PhD
Advertisement
Articles by Maximilian Diehn, MD, PhD
Advertisement
Latest Updated Articles
ctDNA Predicts Outcomes in Lung Cancer Patients Receiving Radiation TherapyPublished: November 14th 2017 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
What is the Impact of the SHARON Trial on Pancreatic Cancer Research?
2
Pembrolizumab/Belzutifan Improves DFS in ccRCC Following Nephrectomy
3
Neoadjuvant Pembrolizumab/Radiotherapy Earns EU Approval in HNSCC Group
4
Pelareorep Combo Yields Responses in Squamous Cell Anal Carcinoma
5
